Shopping Cart
- Remove All
- Your shopping cart is currently empty
Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $43 | In Stock | |
10 mg | $68 | In Stock | |
25 mg | $137 | In Stock | |
50 mg | $223 | In Stock | |
100 mg | $358 | In Stock | |
200 mg | $497 | In Stock | |
1 mL x 10 mM (in DMSO) | $48 | In Stock |
Description | Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma. |
Alias | SHP-141 |
Molecular Weight | 323.34 |
Formula | C16H21NO6 |
Cas No. | 946150-57-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 150 mg/mL (463.91 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.